论文部分内容阅读
目的通过综合评价比较经尿道前列腺汽化电切(TUVP)和经尿道前列腺等离子剜除术(PKEP)治疗良性前列腺增生症(BPH)的临床疗效和可行性。方法回顾性分析66例BPH患者的手术方式,就手术时间、术中出血量、膀胱冲洗时间、术中电切综合症(TURS)发生率、术后国际前列腺症状评分(I-PSS)、生活质量评分(QOL)、最大尿流率(Qmax)和剩余尿(PVR)以及术后并发症的发生率进行比较。结果32例行TUVP术,34例行PKEP术,术前两组患者一般情况比较无统计学差异(p>0.05);术后各组患者I-PSS、QOL、Qmax、PVR与术前比较均有显著性差异(p<0.01),但组间比较均无显著性差异(p>0.05)。手术时间、术中出血量、术后膀胱冲洗时间、住院时间PKEP组明显小于TUVP组,术后3个月内的排尿困难、继发性出血多见于TUVP。结论PKEP与TUVP对治疗BPH疗效无显著性差异,但PKEP在缩短手术时间和住院时间,减少并发症方面有明显优势。
Objective To evaluate the clinical efficacy and feasibility of a comprehensive evaluation of transurethral vaporization of the prostate (TUVP) and transurethral resection of the prostate (PKEP) for benign prostatic hyperplasia (BPH). Methods A retrospective analysis of 66 cases of BPH surgery, surgical time, intraoperative blood loss, bladder irrigation time, surgical resection syndrome (TURS) incidence, postoperative International Prostate Symptom Score (I-PSS), life Quality of care (QOL), maximum flow rate (Qmax) and residual urine (PVR) and the incidence of postoperative complications were compared. Results TUVP was performed in 32 cases and PKEP was performed in 34 cases. There was no significant difference in the general conditions between the two groups before surgery (p> 0.05). The postoperative I-PSS, QOL, Qmax and PVR There was significant difference (p <0.01), but there was no significant difference between the two groups (p> 0.05). Surgery time, intraoperative blood loss, postoperative bladder irrigation time, hospital stay PKEP group was significantly less than the TUVP group, dysuria within 3 months after surgery, more common in secondary bleeding TUVP. Conclusion There is no significant difference between PKEP and TUVP in the treatment of BPH. However, PKEP has obvious advantages in shortening the operation time and hospitalization time and reducing complications.